Effects of Acute Tryptophan Depletion on Mood and Cortisol Release in First-degree Relatives of Type I and Type II Bipolar Patients and Healthy Matched Controls

Neuropsychopharmacology

Volumn 27, Issue 5, 2002, Pages 834-842

  Sobczak, S ^a   Honig, A ^a   Nicolson, N A ^a   Riedel, W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Bipolar disorder; Cortisol; Family history; Mood; Serotonin; Tryptophan depletion

Indexed keywords

HYDROCORTISONE; TRYPTOPHAN;

ADULT; AMINO ACID ANALYSIS; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH STATUS; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; MALE; MOOD; PRIORITY JOURNAL; RELATIVE; SEROTONINERGIC SYSTEM; SPEECH; STRESS; TASK PERFORMANCE;

ADULT; AFFECT; BIPOLAR DISORDER; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FAMILY; FEMALE; HUMANS; HYDROCORTISONE; LINEAR MODELS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TRYPTOPHAN;

EID: 0036848455     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00345-7     Document Type: Article

References (55)

1. Abel K.M., Cleare A.J. Peripheral hormonal responses to D-fenfluramine as a probe of central serotonergic function in humans. Psychopharmacol. 142:1999;68-72.
2. Aberg-Wistedt A., Hasselmark L., Stain-Malmgren R., Aperia B., Kjellman B.F., Mathe A.A. Serotonergic vulnerability in affective disorder. a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders Acta Psychiatr Scand. 97:1998;374-380.
3. Ansseau M., Sulon J., Doumont A., Cerfontaine J.L., Legros J.J., Sodoyez J.C., Demey-Ponsart E. Use of saliva cortisol in the dexamethasone suppression test. Psychiatry Res. 13:1984;203-211.
4. Arrindell WA, Ettema JHM (1986): SCL-90. Een multidimensionele psychopathologie indicator [SCL-90. A multidimensional indicator of psychopathology]. Swets & Zeitlinger, Lisse, The Netherlands
5. Asberg M. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann N Y Acad Sci. 836:1997;158-181.
6. Bellivier F., Leboyer M., Courtet P., Buresi C., Beaufils B., Samolyk D., Allilaire J., Feingold J., Mallet J., Malafosse A. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry. 55:1998;33-37.
7. Benkelfat C., Ellenbogen MA Dean P, Palmour RM, Young SN Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry. 51:1994;687-697.
8. Benkelfat C., Seletti B., Palmour R.M., Hillel J., Ellenbogen M., Young S.N. Tryptophan depletion in stable lithium-treated patients with bipolar disorder in remission. Arch Gen Psychiatry. 52:1995;154-156. [letter; comment].
9. Bond A., Lader M. The use of analogue scales in rating subjective feelings. Br J Med Psych. 80:1974;1-46.
10. Cappiello A., Sernyak M.J., Malison R.T., McDougle C.J., Heninger G.R., Price L.H. Effects of acute tryptophan depletion in lithium-remitted manic patients. a pilot study Biol Psychiatry. 42:1997;1076-1078.
11. Cassidy F., Murry E., Carroll B.J. Tryptophan depletion in recently manic patients treated with lithium. Biol Psychiatry. 43:1998;230-232.
12. Cleare A.J., Murray R.M., Sherwood R.A., O'Keane V. Abnormal 5-HT1D receptor function in major depression. a neuropharmacological challenge study using sumatriptan Psychol Med. 28:1998;295-300.
13. Delgado P.L., Price L.H., Miller H.L., Salomon R.M., Aghajanian G.K., Heninger G.R., Charney D.S. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry. 51:1994;865-874.
14. Delgado P.L., Price L.H., Miller H.L., Salomon R.M., Licinio J., Krystal J.H., Heninger G.R., Charney D.S. Rapid serotonin depletion as a provocative challenge test for patients with major depression. relevance to antidepressant action and the neurobiology of depression Psychopharmacol Bull. 27:1991;321-330.
15. Depue R.A., Slater J., Wolfstetter-Kausch H., Klein D., Goplerud E., Farr D. A behavioral paradigm for identifying persons at risk for bipolar depressive disorder. A conceptual framework and five validation studies J Abnorm Psychol. 90:1981;381-437. [Monograph].
16. Depue R.A., Kleiman R.M., Davis P., Hutchinson M., Krauss S.P. The behavioral high-risk paradigm and bipolar affective disorder, VIII. Serum cortisol in nonpatient cyclothemic subjects selected by the general behavior inventory Am J Psychiatry. 142:1985;175-181.
17. Depue R.A., Krauss S., Spoont M.R., Arbisi P. General behavior inventory identification of unipolar and bipolar affective conditions in a nonclinical university population. J Abnorm Psychol. 98:1989;117-126.
18. Endicott J., Andreasen N.C., Spitzer R.L. Family History -Research Diagnostic Criteria. 1975;Biometrics Research, New York State Psychiatric Institute, New York.
19. Goodwin F., Ghaemi S.N. Understanding manic-depressive illness. Arch Gen Psychiatry. 55:1998;23-25.
20. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 6:1967;278-296.
21. Hughes J.H., Dunne F., Young A.H. Effects of acute tryptophan depletion on mood and suicidal ideation in bipolar patients symptomatically stable on lithium. Br J Psychiatry. 177:2000;447-451.
22. Klaassen T., Riedel W.J., van Someren A., Deutz N.E.P., Honig A., van Praag H.M. Mood effects of 24-hour tryptophan depletion in healthy first degree relatives of patients with affective disorders. Biol Psychiatry. 46:1999;489-497.
23. Klein D., Depue R.A., Slater J. Inventory identification of cyclothymia. IX. Validation in offspring of bipolar I patients Arch Gen Psychiatry. 43:1986;441-445.
24. Krabbendam L., Honig A., Wiersma J., Vuurman E.F.P.M., Hofman P.A.M., Derix M.M.A., Nolen W.A., Jolles J. Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission. Acta Psychiatr Scand. 101:2000;274-280.
25. Kunugi H., Hattori M., Kato T., Tatsumi M., Sakai T., Sasaki T., Hirose T., Nanko S. Serotonin transporter gene polymorphisms. ethnic difference and possible association with bipolar affective disorder Mol Psychiatry. 2:1997;457-462.
26. Leake A., Fairbairn A.F., McKeith I.G., Ferrier I.N. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain. Neurochemical and clinical correlates Psychiatry Res. 39:1991;155-165.
27. Luteijn F. Een nieuwe verkorte versie van de Groningen Intelligentie Test. Ned Tijdschr Psychol. 21:1966;675-682. [A new abbreviated Groninger Intelligence Test].
28. Marazziti D., Lenzi A., Cassano G.B. Serotoninergic dysfunction in bipolar disorder. Pharmacopsychiatry. 24:1991;164-167.
29. McNair D.M., Lorr M., Droppleman L.F. Manual for the profile of mood states. 1971;Educational and Industrial Testing Services, San Diego, CA.
30. Meltzer H.Y., Perline R., Tricou B.J., Lowy M., Robertson A. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms. Arch Gen Psychiatry. 41:1984;379-387.
31. Menkes D.B., Coates D.C., Fawcett J.P. Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord. 32:1994;37-44.
32. Moreno F.A., Heniger G.R., McGahuey C.A., Delgado P.L. Tryptophan depletion and risk of depression relapse. a prospective study of tryptophan depletion as a potential predictor of depressive episodes Biol Psychiatry. 48:2000;327-329.
33. Nicolson N., Storms C., Ponds R., Sulon J. Salivary cortisol levels and stress reactivity in human aging. J Geront: Med Sci. 52A:1997;M68-M75.
34. Nordstrom P., Samuelsson M., Asberg M., Traskman-Bendz L., Asberg-Wistedt A., Nordin C., Bertilsson L. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav. 24:1994;1-9.
35. Nurnberger J.I. Jr., Berrettini W., Simmons Alling S., Lawrence D., Brittain H. Blunted ACTH and cortisol response to afternoon tryptophan infusion in euthymic bipolar patients. Psychiatry Res. 31:1990;57-67.
36. Oruc L., Verheyen G.R., Furac I., Jakovljevic M., Ivezic S., Raeymaekers P., Van Broeckhoven C. Association analysis of the 5-HT2C receptor and 5-HT transporter genes in bipolar disorder. Am J Med Genet. 74:1997;504-506.
37. Pfeffer C.R., McBride P.A., Anderson G.M., Kakuma T., Fensterheim L., Khait V. Peripheral serotonin measures in prepubertal psychiatric inpatients and normal children. associations with suicidal behavior and its risk factors Biol Psychiatry. 44:1998;568-577.
38. Price L.H., Charney D.S., Delgado P.L., Heniger G.R. Lithium and serotonin function:implications for the serotonin hypothesis of depression. Psychopharmacol. 100:1990;3-12.
39. Rasgon N., McGuire M., Tanavoli S., Fairbanks L., Rapkin A. Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome. Fertil Steril. 73:2000;144-149.
40. Rihmer Z., Pestality P. Bipolar II disorder and suicidal behavior. Psychiatr Clin North Am. 22:1999;667-673.
41. Schmitt J.A.J., Jorissen B.L., Sobczak S., Van Boxtel M.P.J., Hogervorst E., Deutz N.E.P., Riedel W.J. Tryptophan depletion impairs memory consolidation, but improves focused attention in healthy young volunteers. J Psychopharmacol. 14:2000;21-29.
42. Sharma R.P., Shapiro L.E., Kamath S.K., Soll E.A., Watanabe M.D., Davis J.M. Acute dietary tryptophan depletion. effects on schizophrenic positive and negative symptoms Neuropsychobiology. 35:1997;5-10.
43. Sheehan D, Lecrubier Y, Janavs J, Knapp E, Weiller E (1994): MINI International Neuropsychiatric Interview. Tampa, FL, University of South Florida
44. Smith K.A., Fairburn C.G., Cowen P.J. Relapse of depression after rapid depletion of tryptophan. Lancet. 349:1997;915-919.
45. Sobczak S., Honig A., Riedel W.J. Acute tryptophan depletion in bipolar disorders; literature review and directives for further research. Acta Neuropsychiatrica. 12:2000;69-72.
46. Sobczak S., Riedel W.J., Booij L., aan het Rot M., Deutz NEP Honig A Cognition following acute tryptophan depletion. differences between first-degree relatives of bipolar disorder patients and matched healthy control volunteers Psychol Med. 32:2002;503-515.
47. Swann A.C., Stokes P.E., Casper R., Secunda S.K., Bowden C.L., Berman N., Katz M.M., Robins E. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand. 85:1992;270-274.
48. van Eck M.M., Nicolson N.A., Berkhof H., Sulon J. Individual differences in cortisol responses to a laboratory speech task and their relationship to responses to stressful daily events. Biol Psychol. 43:1996;69-84.
49. van Eijk H.M., Rooyakkers D.R., Deutz N.E. Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2-3 microns Spherisorb ODS II column. J Chromatogr. 620:1993;143-148.
50. Vieta E., Martinez-De-Osaba M.J., Colom F., Martinez-Aran A., Benabarre A., Gasto C. Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients. Psychol Med. 29:1999;971-978.
51. Wirz Justice A., Puhringer W. Increased platelet serotonin in bipolar depression and hypomania. J Neural Transm. 42:1978;55-62.
52. Young L.T., Warsh J.J., Warsh J.J., Kish S.J., Shannak K., Hornykeiwicz O. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry. 35:1994;121-127.
53. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania. reliability, validity and sensitivity Br J Psychiatry. 133:1978;429-435.
54. Young S.N. Some effects of dietary components (amino acids, carbohydrate, folic acid) on brain serotonin synthesis, mood, and behavior. Can J Physiol Pharmacol. 69:1991;893-903.
55. Young S.N., Smith S.E., Pihl R.O., Ervin F.R. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berl). 87:1985;173-177.